10x Genomics Wins Permanent Injunction Against NanoString (NASDAQ:TXG)


10x Genomics Headquarters in the East San Francisco Bay Area

Miscellaneous photography/iStock Editorial via Getty Images

  • Genomics 10X (Nasdaq:TXG) won a permanent injunction against NanoString Technologies in a patent dispute.
  • A permanent injunction will be issued on Jan. 10, U.S. District Judge Matthew F. Kennelly wrote in an opinion Monday.
  • Bruker (BRKR) acquired NanoString



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending now

Chelsea could regret having sold “one of the best” in PL
In Response to Screen Rant Owner’s Lawsuit Threats, They Demand Removal of Reports
Hearn angry when Inoue rejects Akhmadaliev fight, cites Tapales loss
WATCH: Axar Patel’s fielding brilliance saves a certain six in DC vs MI clash at IPL 2025
//madurird.com/4/8681975